
Coeliac disease is a systemic immune-mediated disorder triggered by gluten ingestion in genetically predisposed individuals, affecting approximately 1% of the population. Strict gluten-free diet remains the only effective treatment, with variable mucosal healing and ongoing vigilance for complications. Novel pharmacological therapies, including latiglutenase and transglutaminase inhibitors, are advancing through clinical trials.